Enzolytics Inc (ENZC): But you were pumping your ass off and Pr...

I-Glow · 2025-02-13T23:12:42.4400000Z

But you were pumping your ass off and Praising Chandra - now you are panhandling for donations to the fake lawsuit. Why won't you name the Law firm? IG

Play Episode

5min

Proactive - Interviews for investors

Blockmate Ventures: Hivello’s AI expansion with Nosana

Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF) chairman Domenic Carosa talked with Proactive's Stephen Gunnion about Hivello’s latest integration with the Nosana network. Carosa explained that Hivello allows users to rent out their computer resources, similar to how AirBnB operates for homes. This model enables users to generate passive income while contributing to a decentralized blockchain network. The integration with Nosana enhances this model by tapping into AI demand. “Nosana is one of the leading GPU DePINs… they basically power AI,” Carosa said. He highlighted that Hivello’s users are now actively contributing to training AI models and earning from it. Carosa also discussed the recent token generation event (TGE), comparing it to an IPO in the crypto space. As of the interview, Hivello’s token had a fully diluted value of over $20 million, providing significant value to Blockmate Ventures, which owns approximately 50% of Hivello. Looking ahead, Blockmate Ventures is focused on expanding its DePIN integrations and increasing customer adoption. Carosa emphasized that the company is doubling down on AI and blockchain opportunities in 2025. For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for the latest insights! #BlockmateVentures #Hivello #Nosana #AI #DePIN #Crypto #Blockchain #TokenGeneration #Web3 #PassiveIncome #TechInvesting

Proactive - Interviews for investors

Nostra Terra Oil and Gas completes fundraise as it advances Pine Mills workovers

Nostra Terra Oil and Gas Company PLC (AIM:NTOG, OTC:NTOGF) CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s latest developments, including its recently completed £500,000 fundraise. The funds will be used to complete the phase two workover program at Pine Mills, addressing well integrity issues and optimising oil production. Welch highlighted that the company is currently profitable at existing oil prices and remains focused on maximising the potential of Pine Mills before exploring new opportunities. He also discussed the ongoing technical evaluation of the Fouke three location with their partner, with further updates expected. Welch noted that the water flood program, which restarted in September, has exceeded expectations, leading to increased oil production. As a result, part of the funds raised will go towards upgrading two pumping units to support higher output. Looking ahead, Welch emphasised that Nostra Terra is focused on maintaining a solid, profitable base while evaluating further growth opportunities. He pointed out that the company has additional behind-pipe opportunities and untapped potential within Pine Mills, positioning it for continued success. For more updates on Nostra Terra Oil and Gas, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for more interviews and insights. #NostraTerra #OilAndGas #EnergyInvesting #OilProduction #Fundraising #Investing #StockMarket #EnergySector #OilIndustry #TexasOil

Proactive - Interviews for investors

Empire Metals MD on high-purity titanium breakthrough

Empire Metals Ltd (AIM:EEE) managing director Shaun Bunn talked with Proactive about the company's latest metallurgical test results at the Pitfield project. The test work delivered an impressive 91.6% purity titanium dioxide compound—achieved on the first attempt. Bunn emphasised that this high-grade product is free from deleterious contaminants, making it suitable for further processing into titanium sponge metal or premium-grade titanium pigments. He explained that the team successfully extracted and refined the titanium-bearing minerals using gravity separation, flotation, and acid digestion techniques. The company is now focused on optimising its processing flow sheet and scaling up test work. Recent bulk metallurgical sample collections at Pitfield will support larger-scale testing, with the goal of producing more of this high-grade product for market analysis. Bunn also highlighted that the simplicity of Pitfield's mineral composition, free from heavy metals or radioactive elements, has contributed to the rapid progress in refining processes. With further purification testing ahead, Empire Metals is poised to advance its titanium strategy. For more insights from this interview, visit Proactive’s YouTube channel. Don't forget to like, subscribe, and turn on notifications for future updates. #EmpireMetals #Titanium #Mining #PitfieldProject #Metallurgy #TitaniumDioxide #MineralProcessing #MiningStocks #TitaniumSponge #Investing

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Followers	741
Posts	77684
Boards Moderated	0
Alias Born	01/01/2012

Volume:	1,263,319
Day Range:	0.0007 - 0.0008
Bid:	0.0007
Ask:	0.0008
Last Trade Time:	3:47:59 PM EDT
Total Trades:	21

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

ENZC Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free